Philippe Margaron
Corporate Officer/Principal bei University of British Columbia
Profil
Philippe Margaron is an Adjunct Professor at the University of British Columbia since 2011.
He previously worked as the Director-Ocular Research at QLT, Inc. from 2010 to 2011.
Before that, he was the Head-Preclinical Department at Iris Pharma SAS.
Dr. Margaron also served as the Vice President-Research & Development at Charlesson LLC.
He obtained his doctorate degree from Université Pierre et Marie Curie in 1991.
Aktive Positionen von Philippe Margaron
| Unternehmen | Position | Beginn |
|---|---|---|
| University of British Columbia | Corporate Officer/Principal | 24.06.2010 |
Ehemalige bekannte Positionen von Philippe Margaron
| Unternehmen | Position | Ende |
|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
Iris Pharma SAS
 Iris Pharma SAS Miscellaneous Commercial ServicesCommercial Services Iris Pharma SARL specializes in pre-clinical and clinical research in ophthalmology. The firm engages in drug discovery, ophthalmic preclinical development, and ophthalmic clinical development. The company was founded by Pierre-Paul Elena and is headquartered in La Gaude, Italy. | Corporate Officer/Principal | - |
Charlesson LLC
 Charlesson LLC Pharmaceuticals: MajorHealth Technology Charlesson LLC engages in the development of therapeutics for treating debilitating ophthalmic diseases. The firm product pipeline includes pharmaceutical treatments for age-related macular degeneration, diabetic retinopathy, ocular inflammation, angiogenesis, and systemic diabetes. The company was founded by Jian-Xing Ma and Yan Feng in 2003 and is headquartered in Oklahoma City, OK. | Technik-/Wissenschafts-/F&E-Leiter | 24.06.2010 |
Ausbildung von Philippe Margaron
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
| Université Pierre et Marie Curie | Consumer Services |
Iris Pharma SAS
Iris Pharma SAS Miscellaneous Commercial ServicesCommercial Services Iris Pharma SARL specializes in pre-clinical and clinical research in ophthalmology. The firm engages in drug discovery, ophthalmic preclinical development, and ophthalmic clinical development. The company was founded by Pierre-Paul Elena and is headquartered in La Gaude, Italy. | Commercial Services |
Charlesson LLC
Charlesson LLC Pharmaceuticals: MajorHealth Technology Charlesson LLC engages in the development of therapeutics for treating debilitating ophthalmic diseases. The firm product pipeline includes pharmaceutical treatments for age-related macular degeneration, diabetic retinopathy, ocular inflammation, angiogenesis, and systemic diabetes. The company was founded by Jian-Xing Ma and Yan Feng in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
